New Random Integration Transgenic Animal Model Generation Solution Available Rensselaer, NY — December 3, 2020 - Taconic Biosciences, a... Read More
Taconic Biosciences Expands Innovative ExpressMODEL® Portfolio
Dec 03, 2020
New Random Integration Transgenic Animal Model Generation Solution Available Rensselaer, NY — December 3, 2020 - Taconic Biosciences, a... Read More
Mouse models are playing an integral role in COVID-19 drug discovery, both for vaccines and targeted therapeutics. In an... Read More
Immediate availability of hACE2 mouse Rensselaer, NY — October 26, 2020 - Taconic Biosciences, a global leader in providing... Read More
Aged models are vital for studying neurodegenerative diseases that develop later in life, but managing these colonies proves challenging.... Read More
Humanized immune system (HIS) models have demonstrated utility in early-stage drug discovery across a range of therapeutic areas. In... Read More
Research into COVID-19 is rapidly evolving, and Taconic Biosciences' Dr. Megan MacBride explains in a recent article in Drug... Read More
The more investigators learn about the microbiome, the more it becomes clear that it impacts both disease development and... Read More
In a recent article published in Drug Discovery News, Taconic's Dr. Terina Martinez explains how behavior is influenced by... Read More
Non-alcoholic fatty liver disease (NAFLD) is a growing concern for clinicians and researchers, alike. One key problem with understanding... Read More
The microbiome is increasingly cited as a key regulator of health and disease. This article published in Lab Animal... Read More
Welcome! Tell us a little about yourself